Inovio Pharmaceuticals (0A43) Income Statement
Inovio Pharmaceuticals Income Statement
Last quarter (Q2 2026), Inovio Pharmaceuticals's total revenue was $0.00. In Q2, Inovio Pharmaceuticals's net income was $-6.01M. See Inovio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 65.34K | $ 217.76K | $ 832.01K | $ 10.26M | $ 1.77M | |
| $ 65.34K | $ 217.76K | $ 832.01K | $ 10.26M | $ 1.77M | |
| $ 86.89M | $ 112.62M | $ 144.77M | $ 277.84M | $ 302.99M | |
| Depreciation and Amortization | $ 2.99M | $ 3.13M | $ 3.50M | $ 5.50M | $ 4.73M |
| $ -81.96M | $ -103.95M | $ -130.39M | $ -270.90M | $ -296.56M | |
| $ -86.82M | $ -112.40M | $ -143.94M | $ -267.57M | $ -301.22M | |
| $ 1.88M | $ 5.14M | $ 8.82M | $ -12.24M | $ -2.44M | |
| $ -84.95M | $ -107.25M | $ -135.12M | $ -279.82M | $ -303.66M | |
| $ -84.95M | $ -107.25M | $ -135.12M | $ -279.82M | $ -303.66M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.81 | $ -3.95 | $ -6.09 | $ -14.07 | $ -1.42 |
| Diluted EPS | $ -1.81 | $ -3.95 | $ -6.09 | $ -14.07 | $ -1.42 |
| Weighted Average Shares Outstanding | 46.89M | 27.16M | 22.17M | 19.89M | 17.40M |
| Weighted Average Shares Outstanding (Diluted) | 46.89M | 27.16M | 22.17M | 19.89M | 17.40M |
Currency in USD
